Who are the key players in UK Cold Drug Logistics industry?

The top five players in the UK Cold Drug Logistics industry include DHL Supply Chain, Kuehne + Nagel, UPS Healthcare, Movianto, and Alloga UK. These companies provide advanced temperature-controlled transportation and warehousing solutions, ensuring pharmaceutical integrity and regulatory compliance across the cold chain logistics sector.

What is the UK Cold Drug Logistics growth?

The UK Cold Drug Logistics sector has experienced substantial growth, driven by increased demand for temperature-sensitive biopharmaceuticals. In 2023, DHL Supply Chain expanded its cold chain fleet in the UK, reflecting rising investments and a growing market, estimated to witness a CAGR of over 7% through 2027.

Which segment accounted for the largest UK Cold Drug Logistics share?

Pharmaceuticals accounted for the largest share in the UK Cold Drug Logistics market. The segment includes vaccines, biologics, and specialty drugs, which require strict temperature control. The COVID-19 pandemic notably boosted this segment, driving cold chain demand for secure and timely delivery of critical medicines.

What are the factors driving the UK Cold Drug Logistics?

Key factors include rising demand for biologics, expanding vaccine requirements, and stricter regulatory compliance. For instance, Kuehne + Nagel has invested in state-of-the-art temperature-controlled storage technologies, enhancing safe handling of sensitive drugs and meeting the complex logistical requirements of the pharmaceutical sector.

Which type accounted for the largest UK Cold Drug Logistics share?

Refrigerated transportation accounted for the largest share in the UK Cold Drug Logistics market. This type is essential for protecting drug efficacy and safety during transport. Demand has surged due to increased movement of vaccines and biologics, with major players investing heavily in modern refrigerated fleets.

Home Logistics

UK Cold Drug Logistics Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: UK Cold Drug Logistics
Brand: Bussiness Insights

UK Cold Drug Logistics Market: by Type (Airways, Roadways, Waterways, Railways, Integrated), Application (Vaccines, Clinical Trial Materials, Biopharmaceuticals, Samples, Blood Products, Others), Distribution Channels (Direct Tender, Distributors, Online, Retail, Others), Technology (Refrigerated Storage, Real-time Monitoring, RFID, GPS Tracking, Packaging Solutions, Blockchain), Organization Size (Small, Medium, Large) and By UK Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20568 | Author: Mike

RD TOC Segmentation Research Methodology Request For Free Sample Copy

UK Cold Drug Logistics Market Forecast 2025-2035

The UK cold drug logistics market is projected to see robust growth from 2025 to 2035, driven by rising demand for temperature-sensitive pharmaceuticals and advancements in logistics technology. Increased vaccination campaigns, personalized medicine, and a push for supply chain transparency will transform the sector. Strategic investments in real-time monitoring and eco-friendly packaging are shaping competitive dynamics, ensuring the safe delivery of biopharmaceuticals and vaccines across diverse distribution channels.

Latest Market Dynamics

Key Drivers

Surge in biopharmaceuticals and vaccine transportation needs, especially post-pandemic, driven by continual health emergencies and expanding pharmaceutical innovation. DHL Supply Chain, for instance, scaled up its temperature-controlled solutions in 2024.

Adoption of end-to-end digital supply chain monitoring and advanced cold chain technologies to reduce spoilage and losses. UPS Healthcare invested in real-time monitoring and RFID systems across its UK logistics network in early 2024.

Rise of integrated logistics solutions combining multiple transport modes for optimized performance—DHL and Kuehne + Nagel expanded integrated cold chain offerings in 2024.
Growth in eco-conscious initiatives, such as reusable packaging and carbon-neutral transport. CEVA Logistics rolled out sustainable cold chain packaging solutions in Q3 2024.

Key Opportunities

Expansion of cold chain infrastructure in underserved regions, with Agility Logistics entering new Tier 2 UK cities in late 2024.
Leveraging blockchain for traceability—DSV Panalpina partnered on a pharma blockchain pilot, enhancing supply chain visibility from Q4 2024.

Complex regulations and standards for drug logistics across the UK, especially for cross-border movement, challenge compliance. FedEx Express highlighted regulatory adaptation costs in its 2024 UK operations review.
Rising operational costs due to high energy prices and skilled labor shortages, as reported by Movianto's Q2 2024 market update.

Limited cold chain infrastructure in rural and remote regions, restricting market penetration. Polar Speed faced rural delivery bottlenecks in mid-2024.
Supply chain disruptions and fuel volatility impacting timely deliveries and service reliability—Yusen Logistics noted such risks in their 2024 annual report.

UK Cold Drug Logistics Market Share by Type, 2025

To learn more about this report,Download Free Sample Report

Roadways dominate the UK cold drug logistics market in 2025, capturing nearly half the segment share due to extensive domestic coverage and flexibility. Airway solutions, though costlier, hold significant share, serving urgent, high-value consignments such as biologics. Integrated solutions are gaining traction as pharmaceutical clients prioritize seamless, multimodal cold chain operations for efficiency and compliance.

UK Cold Drug Logistics Market Share by Application, 2025

To learn more about this report,Download Free Sample Report

Vaccines lead the application segment in 2025, reflecting sustained COVID-19 and influenza immunization initiatives. Biopharmaceuticals are the second-largest segment, fueled by growth in personalized and advanced therapies. Clinical trial material handling is also sizable, as pharmaceutical R&D pipelines broaden across the UK.

UK Cold Drug Logistics Market Revenue (USD Million), 2020-2035

To learn more about this report,Download Free Sample Report

The UK cold drug logistics market is forecast to grow steadily from USD 2,450 Million in 2020 to USD 5,860 Million by 2035, supported by digitalization, innovation, rising healthcare expenditure, and rigorous demand for vaccine and biologics distribution. CAGR is estimated at 5.7% over 2025–2035, with key gains post-pandemic and further industry professionalization in the next decade.

UK Cold Drug Logistics Market YOY Growth (%), 2020-2035

To learn more about this report,Download Free Sample Report

Year-on-year growth rates for the UK cold drug logistics market saw a peak in the immediate post-pandemic years (2020-2022), leveling to a steady growth path by 2025. Annual increases average around 5–6% from 2025 onward as market penetration and maturity deepen sectoral resilience.

UK Cold Drug Logistics Market Share by Regions, 2025

To learn more about this report,Download Free Sample Report

England comprises the majority of the UK's cold drug logistics market in 2025, largely due to high population density and concentrated pharmaceutical activity. Scotland and Wales collectively contribute a smaller share, driven by growing healthcare infrastructure and cross-border collaboration. Northern Ireland holds a modest share, with growth opportunities in rural supply chain improvements.

UK Cold Drug Logistics Market Players Share, 2025

To learn more about this report,Download Free Sample Report

DHL Supply Chain leads the UK cold drug logistics market in 2025 with its advanced temperature-controlled service network. UPS Healthcare, Kuehne + Nagel, and DB Schenker maintain significant shares, leveraging expansive fleet capacity and integrated IT platforms. Other global specialists such as FedEx Express and Marken continue to compete in niche and high-growth contract segments.

UK Cold Drug Logistics Market Buyers Share, 2025

To learn more about this report,Download Free Sample Report

Pharmaceutical manufacturers represent the largest buyer group in the UK cold drug logistics market for 2025, reflecting their lead role in end-to-end drug supply chains. Hospital pharmacies and public health authorities also account for notable shares due to ongoing immunization drives and critical biopharma needs. Clinical research organizations are becoming prominent buyers as research intensifies.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	3200
Regions	England, Scotland, Wales, Northern Ireland
Segments	Type: Airways, Roadways, Waterways, Railways, Integrated; Application: Vaccines, Clinical Trial Materials, Biopharmaceuticals, Samples, Blood Products, Others; Distribution Channels: Direct Tender, Distributors, Online, Retail, Others; Technology: Refrigerated Storage, Real-time Monitoring, RFID, GPS Tracking, Packaging Solutions, Blockchain; Organization Size: Small, Medium, Large
Players	DHL Supply Chain, UPS Healthcare, Kuehne + Nagel, DB Schenker, Nippon Express, FedEx Express, Agility Logistics, Yusen Logistics, CEVA Logistics, DSV Panalpina, Marken, World Courier, Biocair, Movianto, Polar Speed

Key Recent Developments

June 2024: DHL Supply Chain unveils expanded real-time cold chain monitoring offering targeting personalized medicine distribution across the UK.
July 2024: UPS Healthcare achieves GDP certification for its new logistics hub in Manchester, optimizing pharmaceutical handling.
August 2024: CEVA Logistics introduces sustainable cold packaging solutions, reducing the carbon footprint of pharmaceutical shipments in the UK.
June 2024: DSV Panalpina announces pilot blockchain project for full pharma supply chain traceability in partnership with a leading UK pharma company.
July 2024: FedEx Express expands temperature-controlled delivery fleet to rural UK regions, improving last-mile vaccine distribution.

Frequently Asked Questions

About the Author

Mike

Lead Industry Analyst

Mike is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Logistics. Mike brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Mike has helped organizations translate data into actionable growth strategies.

LogisticsMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

UK Cold Drug Logistics Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

UK Cold Drug Logistics Market Forecast 2025-2035

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

UK Cold Drug Logistics Market Share by Type, 2025

UK Cold Drug Logistics Market Share by Application, 2025

UK Cold Drug Logistics Market Revenue (USD Million), 2020-2035

UK Cold Drug Logistics Market YOY Growth (%), 2020-2035

UK Cold Drug Logistics Market Share by Regions, 2025

UK Cold Drug Logistics Market Players Share, 2025

UK Cold Drug Logistics Market Buyers Share, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports